Verona Pharma doses first patient in cystic fibrosis trial

4th April 2017 Uncategorised 0

Verona Pharma has enrolled and dosed the first patient in a clinical study assessing its investigational drug RPL554 as a treatment for cystic fibrosis (CF).

More: Verona Pharma doses first patient in cystic fibrosis trial
Source: News